179 related articles for article (PubMed ID: 25129293)
1. 10-year risk for atherosclerotic cardiovascular disease and coronary heart disease among Korean adults: findings from the Korean National Health and Nutrition Examination Survey 2009-2010.
Lee K
Int J Cardiol; 2014 Sep; 176(2):418-22. PubMed ID: 25129293
[TBL] [Abstract][Full Text] [Related]
2. The ACC/AHA 2013 pooled cohort equations compared to a Korean Risk Prediction Model for atherosclerotic cardiovascular disease.
Jung KJ; Jang Y; Oh DJ; Oh BH; Lee SH; Park SW; Seung KB; Kim HK; Yun YD; Choi SH; Sung J; Lee TY; Kim SH; Koh SB; Kim MC; Chang Kim H; Kimm H; Nam C; Park S; Jee SH
Atherosclerosis; 2015 Sep; 242(1):367-75. PubMed ID: 26255683
[TBL] [Abstract][Full Text] [Related]
3. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH
JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960
[TBL] [Abstract][Full Text] [Related]
4. Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
Nasir K; Bittencourt MS; Blaha MJ; Blankstein R; Agatson AS; Rivera JJ; Miedema MD; Sibley CT; Shaw LJ; Blumenthal RS; Budoff MJ; Krumholz HM
J Am Coll Cardiol; 2015 Oct; 66(15):1657-68. PubMed ID: 26449135
[TBL] [Abstract][Full Text] [Related]
5. Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern multi-ethnic cohort.
DeFilippis AP; Young R; McEvoy JW; Michos ED; Sandfort V; Kronmal RA; McClelland RL; Blaha MJ
Eur Heart J; 2017 Feb; 38(8):598-608. PubMed ID: 27436865
[TBL] [Abstract][Full Text] [Related]
6. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
[TBL] [Abstract][Full Text] [Related]
7. Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA).
Yeboah J; Sillau S; Delaney JC; Blaha MJ; Michos ED; Young R; Qureshi WT; McClelland R; Burke GL; Psaty BM; Herrington DM
Am Heart J; 2015 Mar; 169(3):387-395.e3. PubMed ID: 25728729
[TBL] [Abstract][Full Text] [Related]
8. Validation of the pooled cohort risk score in an Asian population - a retrospective cohort study.
Chia YC; Lim HM; Ching SM
BMC Cardiovasc Disord; 2014 Nov; 14():163. PubMed ID: 25410585
[TBL] [Abstract][Full Text] [Related]
9. Application of the 2013 American College of Cardiology/American Heart Association Cholesterol Guideline to the Korean National Health and Nutrition Examination Surveys from 1998 to 2012.
Song YS; Oh TJ; Kim KM; Moon JH; Choi SH; Jang HC; Park KS; Lim S
Diabetes Metab J; 2017 Feb; 41(1):38-50. PubMed ID: 28029013
[TBL] [Abstract][Full Text] [Related]
10. Statin Use in Primary Prevention of Atherosclerotic Cardiovascular Disease According to 5 Major Guidelines for Sensitivity, Specificity, and Number Needed to Treat.
Mortensen MB; Nordestgaard BG
JAMA Cardiol; 2019 Nov; 4(11):1131-1138. PubMed ID: 31577339
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population.
Rana JS; Tabada GH; Solomon MD; Lo JC; Jaffe MG; Sung SH; Ballantyne CM; Go AS
J Am Coll Cardiol; 2016 May; 67(18):2118-2130. PubMed ID: 27151343
[TBL] [Abstract][Full Text] [Related]
12. American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
Qureshi WT; Kaplan RC; Swett K; Burke G; Daviglus M; Jung M; Talavera GA; Chirinos DA; Reina SA; Davis S; Rodriguez CJ
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28495699
[TBL] [Abstract][Full Text] [Related]
13. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
Pursnani A; Massaro JM; D'Agostino RB; O'Donnell CJ; Hoffmann U
JAMA; 2015 Jul; 314(2):134-41. PubMed ID: 26172893
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors: The Multi-Ethnic Study of Atherosclerosis.
Patel J; Pallazola VA; Dudum R; Greenland P; McEvoy JW; Blumenthal RS; Virani SS; Miedema MD; Shea S; Yeboah J; Abbate A; Hundley WG; Karger AB; Tsai MY; Sathiyakumar V; Ogunmoroti O; Cushman M; Savji N; Liu K; Nasir K; Blaha MJ; Martin SS; Al Rifai M
JAMA Cardiol; 2021 Oct; 6(10):1161-1170. PubMed ID: 34259820
[TBL] [Abstract][Full Text] [Related]
15. Subclinical Atherosclerosis, Statin Eligibility, and Outcomes in African American Individuals: The Jackson Heart Study.
Shah RV; Spahillari A; Mwasongwe S; Carr JJ; Terry JG; Mentz RJ; Addison D; Hoffmann U; Reis J; Freedman JE; Lima JAC; Correa A; Murthy VL
JAMA Cardiol; 2017 Jun; 2(6):644-652. PubMed ID: 28315622
[TBL] [Abstract][Full Text] [Related]
16. Nonobstructive Coronary Artery Disease by Coronary CT Angiography Improves Risk Stratification and Allocation of Statin Therapy.
Emami H; Takx RAP; Mayrhofer T; Janjua S; Park J; Pursnani A; Tawakol A; Lu MT; Ferencik M; Hoffmann U
JACC Cardiovasc Imaging; 2017 Sep; 10(9):1031-1038. PubMed ID: 28330658
[TBL] [Abstract][Full Text] [Related]
17. The new pooled cohort equations risk calculator.
Preiss D; Kristensen SL
Can J Cardiol; 2015 May; 31(5):613-9. PubMed ID: 25843167
[TBL] [Abstract][Full Text] [Related]
18. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
Rosenblit PD
Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
[TBL] [Abstract][Full Text] [Related]
19. Impact of Replacing the Pooled Cohort Equation With Other Cardiovascular Disease Risk Scores on Atherosclerotic Cardiovascular Disease Risk Assessment (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
Qureshi WT; Michos ED; Flueckiger P; Blaha M; Sandfort V; Herrington DM; Burke G; Yeboah J
Am J Cardiol; 2016 Sep; 118(5):691-6. PubMed ID: 27445216
[TBL] [Abstract][Full Text] [Related]
20. ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study.
Mortensen MB; Nordestgaard BG; Afzal S; Falk E
Eur Heart J; 2017 Feb; 38(8):586-594. PubMed ID: 28363217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
